Smartchoices Summary Plan Description

Total Page:16

File Type:pdf, Size:1020Kb

Smartchoices Summary Plan Description PetSmart, Inc. SmartChoices and Flexible Benefits Plans Summary Plan Description Effective January 1, 2020 TABLE OF CONTENTS Contents OVERVIEW ................................................................................................................................................. 1 BENEFITS AT A GLANCE .................................................................................................................... 2 ELIGIBILITY & PARTICIPATION ............................................................................................................ 4 ENROLLMENT RULES .......................................................................................................................... 4 MAKING CHANGES .............................................................................................................................. 8 WHEN COVERAGE ENDS .................................................................................................................. 11 COBRA CONTINUATION COVERAGE ............................................................................................. 13 MEDICAL BENEFITS ............................................................................................................................... 20 HOW THE PLAN WORKS ................................................................................................................... 20 PLAN TERMS ........................................................................................................................................ 27 HEALTH REIMBURSEMENT ACCOUNT ......................................................................................... 29 PERSONAL HEALTH SUPPORT-CARE MANAGEMENT ............................................................... 32 PRIOR AUTHORIZATION ................................................................................................................... 33 BEHAVIORAL HEALTH BENEFITS .................................................................................................. 37 ADDITIONAL COVERAGE AND PRIOR AUTHORIZATION ......................................................... 38 LIMITS & EXCLUSIONS – MEDICAL BENEFITS............................................................................ 65 FLEXIBLE SPENDING ACCOUNTS ...................................................................................................... 79 HEALTH CARE AND LIMITED PURPOSE FSAs.............................................................................. 80 DEPENDENT DAY CARE FSA ........................................................................................................... 82 FILING CLAIMS FOR FSA REIMBURSEMENT ............................................................................... 84 HEALTH SAVINGS ACCOUNT (HSA) .............................................................................................. 86 PRESCRIPTION DRUG PROGRAM ........................................................................................................ 90 PAYING FOR YOUR PRESCRIPTIONS CHART ............................................................................... 92 PRESCRIPTION MANAGEMENT PROGRAMS ................................................................................ 94 DENTAL BENEFITS ................................................................................................................................. 97 HIGHLIGHTS – DENTAL PLANS I & II ............................................................................................. 97 SCHEDULE OF DENTAL BENEFITS ................................................................................................. 98 LIMITS & EXCLUSIONS – DENTAL PLANS I & II ........................................................................ 100 HIGHLIGHTS – DHMO PLAN ........................................................................................................... 102 DHMO PATIENT CHARGE SCHEDULE ......................................................................................... 102 LIMITS & EXCLUSIONS – DHMO PLAN ........................................................................................ 113 VISION BENEFITS ................................................................................................................................. 115 SUMMARY PLAN DESCRIPTION 2020 LIMITATIONS & EXCLUSIONS – VISION BENEFIT PLAN ......................................................... 115 SCHEDULE OF VISION BENEFITS ................................................................................................. 116 LIFE & AD&D INSURANCE ................................................................................................................. 117 LIFE INSURANCE BENEFITS ........................................................................................................... 117 AD&D BENEFITS ............................................................................................................................... 119 AD&D LIMITS & EXCLUSIONS....................................................................................................... 122 BENEFICIARY .................................................................................................................................... 123 DISABILITY ............................................................................................................................................ 125 SHORT TERM DISABILITY (EXCLUDING NJ, CA, RI, AND WA) .............................................. 125 SCHEDULE OF STD BENEFITS ....................................................................................................... 125 SHORT TERM DISABILITY - NJ, CA, RI, HI, WA .......................................................................... 126 LONG TERM DISABILITY ................................................................................................................ 127 SCHEDULE OF LTD BENEFITS ....................................................................................................... 127 LONG TERM DISABILITY CLAIMS IN NJ, CA, HI, RI AND WA ................................................ 127 LTD LIMITS & EXCLUSIONS........................................................................................................... 129 LTD ADDITIONAL REQUIREMENTS & BENEFITS ..................................................................... 130 PLAN ADMINISTRATION .................................................................................................................... 132 FUNDING & ADMINISTRATION ..................................................................................................... 132 PAYMENT RULES .............................................................................................................................. 132 SUBROGATION RULES .................................................................................................................... 135 WHEN A COVERED PERSON QUALIFIES FOR MEDICARE .......................................................... 140 MEDICARE CROSSOVER PROGRAM ............................................................................................ 140 CLAIMS UNDER ERISA'S CLAIMS AND APPEALS PROCEDURES .............................................. 142 CLAIMS PROCEDURE ....................................................................................................................... 144 APPEAL AND CLAIM PROCEDURES -UNITEDHEALTHCARE ................................................. 145 APPEAL AND CLAIM PROCEDURES – CVS CAREMARK .......................................................... 155 APPEAL AND CLAIM PROCEDURES – CIGNA DENTAL ........................................................... 162 APPEAL AND CLAIM PROCEDURES – CIGNA DISABILITY ..................................................... 164 APPEAL AND CLAIM PROCEDURES – LIFE INSURANCE ......................................................... 167 HIPAA PRIVACY RIGHTS ................................................................................................................ 169 PLAN CHANGES ................................................................................................................................ 172 ERISA RIGHTS.................................................................................................................................... 172 LEGAL OR EQUITABLE ACTION ................................................................................................... 174 QUICK REFERENCE CHART................................................................................................................ 175 GLOSSARY OF DEFINED TERMS ....................................................................................................... 177 FORMS AND NOTICES ......................................................................................................................... 198 SUMMARY PLAN DESCRIPTION 2020 HIPAA NOTICE OF PRIVACY PRACTICES .................................................................................... 199 IMPORTANT NOTICE FROM PETSMART ABOUT YOUR PRESCRIPTION DRUG COVERAGE & MEDICARE...................................................................................................................................... 205 INITIAL NOTICE OF COBRA RIGHTS ............................................................................................ 207 SPECIAL RIGHTS FOLLOWING MASTECTOMY ......................................................................... 210 MOTHER’S
Recommended publications
  • Correction of Skeletal Discrepancy and Facial Aesthetics by Combination of Orthodontic Management and Orthognathic Surgery MN Hasana , MB Alamb, MSR Khanc
    Journal of Bangladesh College of Physicians and Surgeons Vol. 32, No. 4, October 2014 Correction of Skeletal Discrepancy and Facial Aesthetics by Combination of Orthodontic Management and Orthognathic Surgery MN HASANa , MB ALAMb, MSR KHANc Summary: alone. This study describes a case of a 26years old Clinical management of non-growing adult patients with Bangladeshi female presented with bimaxillary protrusion dentofacial deformity could be provided with better treated with the combination of orthodontic and outcome when approach in-combined with orthodontic orthognathic surgery. and orthognathic surgery than that of single approach (J Banagladesh Coll Phys Surg 2014; 32: 235-240) Introduction: Orthodontic management of bimaxillary protrusion A bimaxillary protrusion is a condition in which the cases usually involving additional anchorage control maxillary and the mandibular incisor teeth protrude using trans-palatal bar, reverse pull headgear, and more severely so that the lips cannot be closed together. The recently mini-implant.5,6 However treatment time condition is usually considered as an Angle Class I duration of more than years requires depending upon malocclusion,1 and the anterior teeth are well aligned. the severity of malocclusion.7 So in present case it was However, it sometimes shows either mild crowding or planned for a combination of orthodontic and spacing or mild vertical discrepancies ranging from orthongathic surgery to get a more predictable outcome an open bite to a deep bite.2 The majority of patients within a short time duration. Pre-surgical orthodontics who suffer from this condition seek treatment more and postsurgical orthodontic management and for the enhancement of facial esthetics than for dental orthognathic surgery with extraction of all permanent esthetics and function.3 Facial esthetic problems first premolar, a maxillary anterior segmental osteotomy related to bimaxillary protrusion include extreme and a mandibular anterior subapical osteotomy was protrusion of the anterior teeth, lip incompetence, and planned for.
    [Show full text]
  • 0637-129-01 G Ultrapulse CO2 Laser Op Manual English.Book
    UltraPulse® Carbon Dioxide Laser Operator Manual for EncoreTM and SurgiTouchTM Models This manual is copyrighted with all rights reserved. Under copyright laws, this manual may not be copied in whole or in part or reproduced in any other media without the express written permission of Lumenis. Permitted copies must carry the same proprietary and copyright notices as were affixed to the original. Under the law, copying includes translation into another language. Please note that while every effort has been made to ensure that the data given in this document is accurate, the information, figures, illustrations, tables, specifications, and schematics contained herein are subject to change without notice. Lumenis, the Lumenis logo, UltraPulse, UltraPulse SurgiTouch, SurgiTouch+, Encore, UltraScan CPG, PigmentFX, ActiveFX, ActiveFX gentle, MaxFX, DeepFX, SCAAR FX, PreciseFX, IncisionFX, BrowFX, CoolScan, CO2 Lite, TrueSpot, ClearSpot, UltraFlex, Lumenis/Nezhat, AcuSpot, OtoScan, OtoLAM, AcuBlade, BeamAlign, MicroSlad, and FiberLase are trademarks or registered trademarks of Lumenis. Retin-A and Renova are registered trademarks of Ortho Pharmaceuticals Corporation, Dermatological Division. Melanex is a registered trademark of Neutrogena Dermatologics. Valtrex is a registered trademark of Glaxo Wellcome, Inc. Famvir is a registered trademark of SmithKline Beecham Pharmaceuticals. Cipro is a registered trademark of Bayer Corporation. Coppertone and Shade are trademarks, distributed by Schering-Plough HealthCare Products, Inc. Vaseline is a registered trademark of Chesebrough-Pond’s USA, Co. Acutane is a registered trademark of Roche Laboratories, Inc. Copyright© Lumenis Ltd. Authorized Representative: May 2012 Lumenis GmbH Germany 0637-129-01 Heinrich-Hertz-Strasse 3 Revision G D-63303 Dreieich-Dreieichenhain Germany Manufactured by Lumenis Ltd. P.
    [Show full text]
  • National Institute for Health and Care Excellence
    IP1242 [IPG509] NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of hysteroscopic metroplasty of a uterine septum for primary infertility or recurrent miscarriage In some women the uterus (womb) is divided into 2 halves by a thin wall of tissue, called a septum. This may affect fertility and increase the risk of miscarriage. In hysteroscopic metroplasty a thin tube with a camera on the end (a hysteroscope) is inserted into the vagina, through the cervix and into the womb. Instruments are passed through the hysteroscope into the womb and the septum is removed. Introduction The National Institute for Health and Care Excellence (NICE) has prepared this interventional procedure (IP) overview to help members of the Interventional Procedures Advisory Committee (IPAC) make recommendations about the safety and efficacy of an interventional procedure. It is based on a rapid review of the medical literature and specialist opinion. It should not be regarded as a definitive assessment of the procedure. Date prepared This IP overview was prepared in April 2014 and updated in November 2014. Procedure name Hysteroscopic metroplasty of uterine septum in women with primary infertility or recurrent miscarriage Specialist societies Royal College of Obstetricians and Gynaecologists (RCOG) British Fertility Society. IP overview: hysteroscopic metroplasty of uterine septum in women with primary infertility or recurrent miscarriage 1 of 44 IP1242 [IPG509] Description Indications and current treatment A septate uterus is a type of congenital uterine anomaly, in which the inside of the uterus is divided by a muscular or fibrous wall, called the septum. The septum may be partial or complete, extending as far as the cervix.
    [Show full text]
  • Orthodontic-Treatment.Pdf
    Cochrane Library Cochrane Database of Systematic Reviews Orthodontic treatment for deep bite and retroclined upper front teeth in children (Review) Millett DT, Cunningham SJ, O'Brien KD, Benson PE, de Oliveira CM Millett DT, Cunningham SJ, O'Brien KD, Benson PE, de Oliveira CM. Orthodontic treatment for deep bite and retroclined upper front teeth in children. Cochrane Database of Systematic Reviews 2018, Issue 2. Art. No.: CD005972. DOI: 10.1002/14651858.CD005972.pub4. www.cochranelibrary.com Orthodontic treatment for deep bite and retroclined upper front teeth in children (Review) Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Cochrane Trusted evidence. Informed decisions. Library Better health. Cochrane Database of Systematic Reviews T A B L E O F C O N T E N T S HEADER......................................................................................................................................................................................................... 1 ABSTRACT..................................................................................................................................................................................................... 1 PLAIN LANGUAGE SUMMARY....................................................................................................................................................................... 2 SUMMARY OF FINDINGS.............................................................................................................................................................................
    [Show full text]
  • Review Article on Ayurvedic Aspect of Hairfall *Dr
    © 2019 JETIR March 2019, Volume 6, Issue 3 www.jetir.org (ISSN-2349-5162) Review article on ayurvedic aspect of Hairfall *Dr. Rajveer Sason * Ph.D.Scholar, PG department of Agada Tantra, National Insitute of Ayurveda, Amer Road, Jaipur, 302002 Abstract Hair plays a vital role in the personality of human and for their care we use lots of cosmetic products. The fading (pigmentation problem), dandruff, alopecia (loss of hair) is the major problem associated with hairs. It is said that face is the mirror of our personality and it should be maintained from the hairstyle we keep. In today’s developing world there are lots changes in the eating habits and the lifestyle. Due to which its ill effects are seen on the body and out of which hair is affected the most. And hair fall has erupted as a major problem. In our ancient ayurvedic granthas it is said that hair and nail are the malas of the asthi dhatu ie they develop from the asthi. Kesh shaat (hair fall) is considered a sign of Asthi dhatu kshaya in Vagbhat sutra sthaan 11/19. Ayurved very well defines the hair loss problem as Khalitya and mentions different treatments for the problem. Present paper gives an idea on various causes and management of hairfall. Keywords: hair fall, Kesh shaat, Khalitya Introduction Hair is one of the imperative parts of the body derived from ectoderm of the skin; Hair is a dead part with no nerve connections. The hair follicle has the unique ability to regenerate itself . The basic part of hair is bulb (a swelling at the base which originates from the dermis), root (which is the hair lying beneath the skin surface), shaft (which is the hair above the skin surface).
    [Show full text]
  • Orthodontic Treatment for Prominent Upper Front Teeth (Class II Malocclusion) in Children and Adolescents (Review)
    Cochrane Database of Systematic Reviews Orthodontic treatment for prominent upper front teeth (Class II malocclusion) in children and adolescents (Review) Batista KBSL, Thiruvenkatachari B, Harrison JE, O’Brien KD Batista KBSL, Thiruvenkatachari B, Harrison JE, O’Brien KD. Orthodontic treatment for prominent upper front teeth (Class II malocclusion) in children and adolescents. Cochrane Database of Systematic Reviews 2018, Issue 3. Art. No.: CD003452. DOI: 10.1002/14651858.CD003452.pub4. www.cochranelibrary.com Orthodontic treatment for prominent upper front teeth (Class II malocclusion) in children and adolescents (Review) Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. TABLE OF CONTENTS HEADER....................................... 1 ABSTRACT ...................................... 1 PLAINLANGUAGESUMMARY . 2 SUMMARY OF FINDINGS FOR THE MAIN COMPARISON . ..... 4 BACKGROUND .................................... 6 OBJECTIVES ..................................... 6 METHODS ...................................... 6 RESULTS....................................... 8 Figure1. ..................................... 10 Figure2. ..................................... 15 ADDITIONALSUMMARYOFFINDINGS . 19 DISCUSSION ..................................... 28 AUTHORS’CONCLUSIONS . 29 ACKNOWLEDGEMENTS . 29 REFERENCES ..................................... 30 CHARACTERISTICSOFSTUDIES . 39 DATAANDANALYSES. 81 Analysis 1.1. Comparison 1 Early orthodontic treatment: two-phase versus one-phase treatment, Outcome 1 Outcomes at the
    [Show full text]
  • Certificate of Coverage
    UNITEDHEALTHCARE INSURANCE COMPANY STUDENT INJURY AND SICKNESS INSURANCE PLAN CERTIFICATE OF COVERAGE Designed Especially for the Students of 2021-2022 This Certificate of Coverage is Part of Policy # 2021-1149-1 This Certificate of Coverage (“Certificate”) is part of the contract between UnitedHealthcare Insurance Company (hereinafter referred to as the “Company”) and the Policyholder. Please keep this Certificate as an explanation of the benefits available to the Insured Person under the contract between the Company and the Policyholder. This Certificate is not a contract between the Insured Person and the Company. Amendments or endorsements may be delivered with the Certificate or added thereafter. The Master Policy is on file with the Policyholder and contains all of the provisions, limitations, exclusions, and qualifications of your insurance benefits, some of which may not be included in this Certificate. The Master Policy is the contract and will govern and control the payment of benefits. READ THIS ENTIRE CERTIFICATE CAREFULLY. IT DESCRIBES THE BENEFITS AVAILABLE UNDER THE POLICY. IT IS THE INSURED PERSON’S RESPONSIBILITY TO UNDERSTAND THE TERMS AND CONDITIONS IN THIS CERTIFICATE. COL-17-RI (PY21) CERT 38-1149-1 Table of Contents Introduction ........................................................................................................................................... 1 Section 1: Who Is Covered ................................................................................................................... 1 Section
    [Show full text]
  • Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism
    Review Article Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism Mahyar Ghanaat, MD evaluated based on the Ludwig scale, which ranges from I-III Abstract: Androgenetic alopecia (AGA) is the most common form (Fig. 2).4 These classification systems differ based on the fact of hair loss in men, and female pattern hair loss (FPHL) is the most that hair loss and thinning in men most commonly occurs in common form of hair loss in women. Traditional methods of treating an orderly fashion and involves the temporal and vertex re- hair loss have included minoxidil, finasteride, and surgical trans- gion while sparing the occipital region; diffuse thinning and plantation. Currently there is a myriad of new and experimental loss of density with a normal distribution and maintenance of treatments. In addition, low-level light therapy (LLLT) has recently the frontal hairline is often seen in women.2,4,5,9,10 been approved by the United States Food and Drug Administration The term AGA pertains to the pathophysiology of MPHL, (FDA) for the treatment of hair loss. There are several theories and in which there is an induction of hair loss due to the effects minimal clinical evidence of the safety and efficacy of LLLT, al- of androgens such as testosterone (T) and its derivative di- though most experts agree that it is safe. More in vitro studies are hydrotestosterone (DHT) in genetically susceptible individu- necessary to elucidate the mechanism and effectiveness at the cel- als.2 Recently, authors have argued against the use of the term lular level, and more controlled studies are necessary to assess the AGA in women, as the role of androgens in FPHL is debat- role of this new treatment in the general population.
    [Show full text]
  • Orthodontic Treatment for Deep Bite and Retroclined Upper Front Teeth in Children (Review)
    Orthodontic treatment for deep bite and retroclined upper front teeth in children (Review) Millett DT, Cunningham S, O’Brien KD, Benson PE, Williams A, de Oliveira CM This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2012, Issue 1 http://www.thecochranelibrary.com Orthodontic treatment for deep bite and retroclined upper front teeth in children (Review) Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. TABLE OF CONTENTS HEADER....................................... 1 ABSTRACT ...................................... 1 PLAINLANGUAGESUMMARY . 2 BACKGROUND .................................... 2 OBJECTIVES ..................................... 3 METHODS ...................................... 4 RESULTS....................................... 6 DISCUSSION ..................................... 6 AUTHORS’CONCLUSIONS . 7 ACKNOWLEDGEMENTS . 7 REFERENCES ..................................... 7 DATAANDANALYSES. 8 APPENDICES ..................................... 8 WHAT’SNEW..................................... 10 HISTORY....................................... 10 CONTRIBUTIONSOFAUTHORS . 10 DECLARATIONSOFINTEREST . 11 SOURCESOFSUPPORT . 11 DIFFERENCES BETWEEN PROTOCOL AND REVIEW . .... 11 INDEXTERMS .................................... 11 Orthodontic treatment for deep bite and retroclined upper front teeth in children (Review) i Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. [Intervention Review] Orthodontic
    [Show full text]
  • Photobiomodulation for the Management of Hair Loss
    Henry Ford Health System Henry Ford Health System Scholarly Commons Dermatology Articles Dermatology 12-30-2020 Photobiomodulation for the management of hair loss Angeli E. Torres Henry W. Lim Follow this and additional works at: https://scholarlycommons.henryford.com/dermatology_articles Received: 21 May 2020 | Revised: 27 September 2020 | Accepted: 24 December 2020 DOI: 10.1111/phpp.12649 REVIEW ARTICLE Photobiomodulation for the management of hair loss Angeli Eloise Torres | Henry W. Lim Photomedicine and Photobiology Unit, Department of Dermatology, Henry Ford Abstract Health System, Detroit, MI, USA Photobiomodulation, otherwise known as low-level laser (or light) therapy, is an Correspondence emerging modality for the management of hair loss. Several randomized trials have Henry W. Lim, MD, Department of demonstrated that it is safe and potentially effective on its own or in combination Dermatology, Henry Ford Medical Center, 3031 West Grand Boulevard, Suite 800, with standard therapies. These devices come in many forms including wearable caps Detroit, Michigan 48202, USA. or helmets that afford hands-free and discreet use. Models with light-emitting diodes Email: [email protected] (LEDs) are less expensive compared to laser-based devices and do not require laser safety considerations, thus facilitating ease of home use. Limitations include cost of the unit, risk of information bias, and lack of standardized protocols. Finally, as with any hair loss treatment, patients' expectations with regards to therapeutic outcomes must be managed.
    [Show full text]
  • Early Intervention with High-Dose Steroid Pulse Therapy Prolongs Disease-Free Interval of Severe Alopecia Areata: a Retrospective Study
    Steroid Pulse Therapy for Severe Alopecia Areata Ann Dermatol Vol. 25, No. 4, 2013 http://dx.doi.org/10.5021/ad.2013.25.4.471 ORIGINAL ARTICLE Early Intervention with High-Dose Steroid Pulse Therapy Prolongs Disease-Free Interval of Severe Alopecia Areata: A Retrospective Study Chao-Chun Yang1,2, Chun-Te Lee1, Chao-Kai Hsu1,2, Yi-Pei Lee1, Tak-Wah Wong1, Sheau-Chiou Chao1, Julia Yu-Yun Lee1, Hamm-Ming Sheu1, WenChieh Chen3 1Department of Dermatology, 2Institute of Clinical Medicine, National Cheng Kung University, College of Medicine, Tainan, Taiwan, 3Department of Dermatology and Allergy, Technische Universität München, Munich, Germany Background: Spontaneous recovery of severe alopecia be considered as the first-line treatment for patients with areata is rare and the condition is difficult to treat. Objective: severe AA of recent onset within one year. The aim of this study is to investigate and compare the effects (Ann Dermatol 25(4) 471∼474, 2013) and safety of steroid pulse therapy between oral and intra- venous administrations between 1999 and 2010 at the -Keywords- Department of Dermatology, National Cheng Kung Univer- Alopecia areata, Corticosteroids, Pulse drug therapy, Treat- sity Hospital. Methods: Data were retrospectively retrieved. ment A satisfactory response was defined as more than 75% hair regrowth in the balding area. Results: A total of 85 patients with more than 50% hair loss were identified and treated, INTRODUCTION with an overall satisfactory response rate of 51.8%. The mean follow-up time was 37.6 months, with a relapse rate of Alopecia areata (AA) usually runs an unpredictable course 22.7%.
    [Show full text]
  • Treating Myofunctional Disorders: a Multiple-Baseline Study of a New Treatment Using Electropalatography" (2014)
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Special Education and Communication Disorders Department of Special Education and Faculty Publications Communication Disorders 2014 Treating Myofunctional Disorders: A Multiple- Baseline Study of a New Treatment Using Electropalatography Alana Mantie-Kozlowski Missouri State University - Springfield, [email protected] Kevin M. Pitt University of Nebraska - Lincoln, [email protected] Follow this and additional works at: https://digitalcommons.unl.edu/specedfacpub Part of the Special Education and Teaching Commons, Speech and Hearing Science Commons, and the Speech Pathology and Audiology Commons Mantie-Kozlowski, Alana and Pitt, Kevin M., "Treating Myofunctional Disorders: A Multiple-Baseline Study of a New Treatment Using Electropalatography" (2014). Special Education and Communication Disorders Faculty Publications. 196. https://digitalcommons.unl.edu/specedfacpub/196 This Article is brought to you for free and open access by the Department of Special Education and Communication Disorders at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Special Education and Communication Disorders Faculty Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. digitalcommons.unl.edu Treating Myofunctional Disorders: A Multiple-Baseline Study of a New Treatment Using Electropalatography Alana Mantie-Kozlowski and Kevin Pitt Missouri State University, Springfield Corresponding author — Alana Mantie-Kozlowski: [email protected] ORCID Kevin Pitt https://orcid.org/0000-0003-3165-4093 Abstract Purpose: This study assessed the benefit of using electropalatography (EPG) in treatment aimed at habilitating individuals with nonspeech orofacial myofunc- tional disorders (NSOMD). Method: The study used a multiple-baseline design across 3 female participants who were referred for an evaluation and possible treatment of their NSOMD.
    [Show full text]